In millions, except per share items | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 | Sep-30-14 | Sep-30-13 | Sep-30-12 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K |
Revenues: |
Optics | 23.3 | 23.1 | 19.3 | 23.7 | 21.8 | 19.6 | | 16.1 |
Innovation and Development | 20.5 | 17.6 | 18.0 | | | | | |
Asia | 3.2 | 3.0 | | | | | | |
Contract Research | | | | 19.8 | 18.8 | 21.9 | | 25.3 |
Other | | | | | | 0.8 | | 6.6 |
Total revenues | 43.7 | 40.7 | 37.3 | 43.4 | 40.5 | 42.3 | 42.8 | 47.9 |
Revenue growth [+] | 7.4% | 9.1% | -14.2% | 7.2% | -4.2% | -1.0% | -10.7% | 2.0% |
Optics | 0.9% | 19.6% | -18.6% | 8.7% | 11.2% | | | 1.4% |
Innovation and Development | 16.0% | -2.1% | | | | | | |
Asia | 6.3% | | | | | | | |
Contract Research | | | | 5.3% | -14.5% | | | 1.6% |
Cost of goods sold | 27.6 | 25.4 | 23.4 | 27.8 | 25.5 | 25.6 | 24.7 | 28.4 |
Gross profit | 16.1 | 15.2 | 13.9 | 15.6 | 15.0 | 16.7 | 18.1 | 19.5 |
Gross margin | 36.8% | 37.5% | 37.3% | 35.9% | 37.0% | 39.5% | 42.3% | 40.7% |
Selling, general and administrative [+] | 15.4 | 14.1 | 13.5 | 13.9 | 13.8 | 14.0 | 17.1 | 16.4 |
Sales and marketing | 1.7 | 1.3 | 1.2 | 1.2 | 1.2 | 1.4 | 1.7 | |
General and administrative | 13.7 | 12.7 | 12.4 | 12.8 | 12.6 | 12.6 | 15.4 | 16.4 |
Research and development | 0.6 | 0.8 | 0.9 | 1.0 | 1.2 | 1.3 | 2.3 | 2.8 |
Other operating expenses | | | 0.1 | 0.0 | -0.2 | -1.3 | | 1.7 |
EBITDA [+] | 1.4 | 1.6 | 0.7 | 1.9 | 1.3 | 3.8 | 0.3 | 0.2 |
EBITDA growth | -10.6% | 144.1% | -66.3% | 46.3% | -65.2% | 1391.4% | 3.0% | -92.9% |
EBITDA margin | 3.3% | 3.9% | 1.8% | 4.5% | 3.3% | 9.0% | 0.6% | 0.5% |
Depreciation | 1.3 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 1.6 | 0.9 |
EBITA | 0.1 | 0.5 | -0.5 | 0.8 | 0.3 | 2.9 | -1.3 | -0.6 |
EBITA margin | 0.3% | 1.1% | -1.3% | 2.0% | 0.7% | 6.8% | -3.1% | -1.3% |
Amortization of intangibles | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | | 0.8 |
EBIT [+] | 0.0 | 0.3 | -0.6 | 0.7 | 0.1 | 2.7 | -1.3 | -1.4 |
EBIT growth | -96.5% | -159.1% | -185.7% | 406.7% | -95.0% | -301.1% | -5.7% | -162.2% |
EBIT margin | 0.0% | 0.8% | -1.6% | 1.6% | 0.3% | 6.4% | -3.1% | -3.0% |
Non-recurring items [+] | | 0.2 | | | | | 6.8 | 2.3 |
Asset impairment | | 0.2 | | | | | 6.8 | 2.3 |
Loss (gain) on sale of assets | | | | | | -1.3 | | |
Interest expense | 0.2 | 0.2 | 0.2 | 0.2 | 0.4 | 0.9 | 0.9 | 0.6 |
Interest expense | 0.2 | 0.2 | 0.2 | 0.2 | 0.4 | 0.9 | 0.9 | 0.6 |
Other income (expense), net [+] | | | | -0.1 | -0.1 | 0.2 | | 0.0 |
Gain (loss) on sale of assets | | | 0.1 | 0.0 | -0.2 | -1.3 | | |
Pre-tax income | -0.2 | 0.0 | -0.8 | 0.4 | -0.4 | 2.0 | -9.0 | -4.3 |
Income taxes | 0.2 | -1.6 | -2.7 | 0.1 | 0.0 | 0.0 | -0.3 | 0.0 |
Tax rate | | 8933.3% | 345.2% | 13.2% | 1.7% | | 3.4% | 0.9% |
Minority interest | 0.0 | -0.2 | -0.2 | -0.4 | -0.1 | -0.1 | | |
Net income | -0.4 | 1.8 | 2.2 | 0.7 | -0.2 | 2.1 | -8.7 | -4.3 |
Net margin | -0.8% | 4.3% | 5.9% | 1.6% | -0.6% | 4.9% | -20.4% | -9.0% |
|
Basic EPS [+] | ($0.02) | $0.10 | $0.13 | $0.04 | ($0.01) | $0.13 | ($0.59) | ($0.29) |
Growth | -121.2% | -20.9% | 214.0% | -389.5% | -110.6% | -122.8% | 102.8% | -451.3% |
Diluted EPS [+] | ($0.02) | $0.10 | $0.13 | $0.04 | ($0.01) | $0.13 | ($0.59) | ($0.29) |
Growth | -121.2% | -21.0% | 214.6% | -388.9% | -110.6% | -122.8% | 102.8% | -455.9% |
|
Shares outstanding (basic) [+] | 17.1 | 17.2 | 16.9 | 16.7 | 16.4 | 15.4 | 14.8 | 14.8 |
Growth | -0.6% | 1.5% | 1.5% | 1.6% | 6.4% | 4.1% | 0.0% | -0.8% |
Shares outstanding (diluted) [+] | 17.1 | 17.2 | 16.9 | 16.7 | 16.4 | 15.4 | 14.8 | 14.8 |
Growth | -0.7% | 1.5% | 1.3% | 1.8% | 6.3% | 4.2% | 0.0% | -2.1% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |